Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

345.00p
   
  • Change Today:
      25.00p
  • 52 Week High: 706.00p
  • 52 Week Low: 130.00p
  • Currency: UK Pounds
  • Shares Issued: 4.73m
  • Volume: 289,134
  • Market Cap: £16.31m
  • RiskGrade: 340

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £647,658
Vladislav Sandler Ph.D. 103,862 £358,324
Peter Redmond 13,991 £48,269

Major Shareholders

Notifier** Holding Value*
Alexis Sandler 187,727 £647,658
Dr Vladislav Sandler 103,862 £358,324
Optiva Securities Limited 70,329 £242,635
Flascherberg Capital Anstalt 69,991 £241,469
Craig Auringer 59,593 £205,596
HSBC Client Holdings Nominee (UK) Limited 45,160 £155,802
Ron Valk 42,828 £147,757
Samantha Bauer 42,706 £147,336
Plum Capital 29,232 £100,850
43 North LLC 28,429 £98,080
Abdelatif LACHAB 6,500 £22,425
Wayne Gibson 6,500 £22,425

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 345.00p
Change Today 25.00p
% Change 7.81 %
52 Week High 706.00p
52 Week Low 130.00p
Volume 289,134
Shares Issued 4.73m
Market Cap £16.31m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47% below the market average47% below the market average47% below the market average47% below the market average47% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average
Price Trend
91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average
90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 28-Aug-2025

Time Volume / Share Price
14:23 15,389 @ 362.00p
15:43 33 @ 368.00p
16:18 199 @ 341.50p
16:14 4 @ 340.50p
16:13 64 @ 340.00p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page